Gynecology

Infertility & ART

Fetomaternal Medicine

POSTERS

	Thursday, November 4, 2010
17:30-19:00	Opening Session
	Keynote Lectures - Leaders' prospective on the future Technology-based advances in obstetrics, gynecology and infertility facilitate earlier, less-invasive diagnosis: What does the future hold for our main subdisciplines?
Chairpersons	Z. Ben-Rafael, Israel K. Diedrich, Germany B. Fauser, Netherldands R. Fischer, Germany Z. Shoham, Israel
	Fetomaternal Medicine Genetic diagnosis on fetal cells in maternal blood: Will it ever become routine? G.C. Di Renzo, Italy
	Gyn-Oncology Ovarian Cancer: Can new markers change the fate of the disease? R.G. Moore, USA
	Reproductive Medicine Science vs. Practice P. Patrizio, USA
19:00-20:30	Opening and Cocktails

08:30-10:00	The Challenges of Perinatal Viability
Capsule	Despite great advances in perinatal medicine, the challenges of the gestational period from 22 to 26 weeks are still poignant for the perinatologists
Chairperson	J. Dudenhausen, Germany
	Outcome of the periviable infant: Have we reached the limit? M. Carrapato, Portugal
	What is the best method to deliver very premature babies? D. Skupski, USA
	Economic considerations in the management of the periviable infant M. Carrapato, Portugal
	Ethical dimensions in obstetric and neonatal care of the periviable infant F.A. Chervenak,USA
Objectives	Upon completion of this session, the audience will have learned:
	* To understand the burden of very premature delivery on medical, economical, societal and parental issues * To understand the risk of vaginal vs. Cesarean for periviable infants * To apply ethical principles to challenges evolving from perinatal management of the periviable infant
10:00-10:20	Coffee break

 

10:20-11:50	The Challenge of Membrane Rupture Diagnosis, Chorioamnionitis and Perinatal Infection
Capsule	Chorioamnionitis and Perinatal Infection are major causes of perinatal morbidity and mortality
	Advances in the diagnosis of premature rupture of the membrane
	Controversies in the obstetric management of chorioamnionitis
	Diagnosis and management of chorioamnionitis form the neonatal perspective
Objectives	The accurate diagnosis of premature rupture of membranes
	* To understand the impact of perinatal infection with and without chorioamnionitis * How available tools can enhance diagnosis
11:50-12:10	Poster viewing

12:10-13:40	Prematurity Sponsored by an unrestricted grant from Hologic (UK) Limited
Capsule	Despite the high perinatal morbidity and mortality associated with preterm delivery, no existing tool is specific enough to diagnose premature labor, and no good and reliable intervention is available early enough to interrupt the vicious circle of labor. The question is: Can we really decrease prematurity?
Chairpersons	A. Shennan, UK J. Deprest, Belgium
	Diagnosis of preterm labor (PTL) and prediction of premature delivery: Who to treat, and who not to treat? A. Shennan, UK
	Debate: Is Cervical Length Measurement Necessary over Biochemical Markers to Predict Preterm Birth?!      The combined use of cervical length (CL) and cervicovaginal fetal fibronectin (fFN) in women with threatened preterm labour W. Henrich, Germany Ultrasound cervical length measurement is mandatory during preterm birth assessment B. Arabin, Netherlands Discussion
	What are tocolytics good or bad for? G.C. Di Renzo, Italy
Objectives	Upon completion of this session, the audience will have learned:
	* The pitfalls of diagnosis and treatment of PTL * Selecting who to treat * The place of late cerclage in the management of bulging membranes * Technique, indication, and contraindication of late cerclage
13:40-14:30	Lunch break

14:30-16:00	Timing of Delivery and Intrapartum Complications
Capsule	Despite the well-known perils of delivery, and notwithstanding the advanced methods and tools to diagnose the infrequent conditions that can negatively affect the results it should still be ascertained whether misjudgment and errors will not dominate the delivery room scene. What can we do to minimize the risk in this critical phase of human life?
	How can the risks of labor and delivery by monitoring be minimized?
	Can we prevent complications in high-risk pregnancies (previa, accreta, diabetes, IUGR, abnormal Doppler, olygohydramnios, PIH) by well-timed delivery?
	Fetal resuscitation in labor: Is it feasible?
Objectives	To acquire understanding of the following:
	* How monitoring can decrease risks * How planned delivery can prevent complications * How in utero resuscitation can be achieved * When to induce, and when not to induce
16:00-16:30	Coffee break

16:30-18:00	Progesterone: From Luteal Support to Abortions
Capsule	The growing place of progesterone support during pregnancy, by indication or off label, deserve a critical evaluation. Many recent publications indicate the safety of various preparations in the management of threatened abortion, recurrent abortions, and to reduce preterm labor.
Chairperson	J. Dudenhausen, Germany
	The growing palace of progesterone in prevention of prematurity and pregnancy complications G.C. Di Renzo, Italy
	Improving blood flow with Dydrogesterone as a method to prevent abortions
	Prevention of recurrent abortions and treatment of threatened abortion by progesterone F. Facchinetti Modena, Italy
Objectives	* Understanding the role of different Progeterone compounds in the prevention of early and repeated abortion * Appreciating the increasing role of Progeterone support to prevent premature labour

Saturday, November 6, 2010

08:30-10:00	Avoiding Invasive Prenatal Diagnosis
Capsule	The race to attain a complete, noninvasive prenatal genetic diagnosis remains, as yet, an unachieved goal of perinatology. Nevertheless, refinement of old tools and advances in new tests are indications of the future. What are the hurdles to achieve a noninvasive prenatal genetic diagnosis, and how do ethical and patient choices affect this dilemma?
Chairpersons	J. Deprest, Belgium B. Arabin, Germany
	Only a few anomalies will escape detection with ultrasound and biomarkers: Should we be content with this combined tool?
	Debate: Proposition: Chorionic villous sampling (CVS) is the next step after increased NT A. Anstaklis Greece Opposition: CVS should be performed only if detailed screening for anomalies is negative M. Bronshtein, Israel Discussion
Objectives	Upon completion of this session, the audience will learn:
	* The advantages and limitations of current methods * Recognize all the added values of early ultrasound screening * Recognize the full constellation related to prenatal diagnosis
10:00-10:20	Coffee break

10:20-11:50	Uterine Contractility
Capsule	Controlling uterine contractility to induce or prevent labor is the most important task of current obstetrics. What do we have in hand and what are we striving for?
	Should we use repeated courses of Atosiban?
	What is the best method for induction of labor?
	Carbetocin: A new player on the block?
	Reducing the risk of premature labor by prophylactic progesterone: Is it feasible?
Objective	To understand the role and efficacy of repeated Atosiban administration
	* Methods to induce labor in different settings * New opportunities to prevent premature labor
11:50-12:120	Poster viewing

12:10-13:40	Prediction of Hypertensive Disorders in Pregnancy
Capsule	Hypertensive disorders associated with underlying placental and maternal changes, and are associated with endothelial dysfunction and vasospasm, leading to placental insufficiency and serious consequences to the mother and infant. A major development was achieved in the recent years in identifying various markers and tools for predicting the disorders. In addition to the traditional collection of medical and obstetric history and measurements of blood pressure and urine proteins, the effectiveness of pulsatility index of the uterine artery, pregnancy-associated plasma protein-A, placental growth factor, placental protein 13 (PP13) and direct measurements of endothelial dysfunction were shown to be very promising markers. However, since the exact pathophysiological mechanism leading to this condition is still poorly understood, it is difficult to devise a prevention plan. Hence, the question is: what is the medial benefit for prediction? Could close surveillance of the patient at risk can prevent the pathology or save maternal and fetal life? Should we keep investing in prediction in the absence of an ultimate preventive treatment?
	Prediction of preeclampsia by biomarkers - the scientific and clinical data and prospective for improved perinatal service and prevention B. Huppertz, Austria
	Debate: Should we Strive to Predict Pre-eclampsia? Proposition: Prediction is possible with newer methods and this is the first step towards prevention! B. Huppertz, Austria Opposition: Investing in prediction of pre-eclampsia is futile, since there is no effective treatment Discussion
	What can we learn from measuring endothelial dysfunction?
Objectives	Upon completion of this session, the audience will have learned about: * New research and tools to predict pre-eclampsia * The role of PP-13 measurements * The place of endothelial dysfunction measurements
13:40-14:30	Lunch break

14:30-16:00	3-D and 4-D Ultrasound in Modern Perinatal Medicine and Neurobehavioral Assessment
Capsule	3-D and 4-D sound represents the height of modern ultrasound technology, but the role of this technology remains controversial
Chairpersons	A. Antsaklis, Greece B. Arabin, Germany
	Debate: Should 3-D and 4-D Ultrasound be Used in Every Pregnancy? Pro: A. Kurjak, Croatia Con: F.A. Chervenak, USA Discussion
	Are the current criteria valid for defining a causal relationship for cerebral palsy? I. Blickstein, Israel
	Potential of 3-D and 4-D ultrasound for neurobehavioral assessment in perinatal medicine M. Stanojevic, Hungary
Objectives	Upon completion of this session, the audience will have learned about:
	* To establish whether 3/4-D ultrasound is indicated in every pregnancy? * To establish whether 3/4-D ultrasound is of value for neurobehavioral assessment in perinatal medicine? * To understand the relationship of intrapartum events to cerebral palsy
16:00-16:30	Lunch break

16:30-18:00	Controversies in Prenatal Diagnosis and Therapy
Capsule	Implementing modern diagnosis and therapy continues to provoke controversies
Chairpersons	F.A. Chervenak, USA A. Grunebaum, USA
	Amniocentesis vs. CVS? A. Antsaklis, Greece
	Controversies in the management of twin-to-twin transfusion syndrome D. Skupski, USA
	Fetal therapy J. Deprest, Belgium
Objectives	To appreciate the continuing improvements in obstetrical ultrasound
	* To understand current developments in the management of twin-to-twin transfusion syndrome * To appreciate new developments in invasive fetal therapy

Sunday, November 7, 2010

08:30-10:00	Ultrasound (US) Screening for Anomalies
Capsule	Screening for anomalies with US is widely used. However, many elements of   the examination remain controversial
Chairpersons	J. Deprest, Belgium K. Vetter, Germany
Discussants	M. Bronshtein, Israel A. Kurjak, Croatia A. Antsaklis, Greece M. Stanojevic, Croatia
Hot Controversies	Expert Opinions on:
	Nasal bone: Fact or myth? Can "family album" assist in prenatal US screening? What can be gained by combining transvaginal screening (TVS) with transabdominal screening (TAS) in late (24 weeks) sonographic screening? Does intra-amniotic sludge predict preterm delivery? Can we agree on the definition of Dandy-Walker syndrome in ultrasonography? Early (14-16 weeks) or late (18-22 weeks) screening Amniotic band syndrome: Fact or myth Ultrasound: Its reliability in the diagnosis of placenta accreta and vasa previa Elective fetal reduction: In the early or late first trimester Folic acid: Can it prevent other conditions or only NTD? And at what dose? Elective fetal reduction: In the early or late first trimester
10:00-10:30	Coffee break

10:30-12:30	Controversies over Endless Cesarean Delivery and Multiple Pregnancy
Capsule	Cesarean delivery, the most common surgical procedure performed, continues to generate controversies that challenge all obstetricians. The almost universal use of CS to deliver multiple pregnancies adds to the problem
Chairperson	F.A. Chervenak, USA
	What is the ideal Cesarean delivery rate? B. Serra, Spain
	Patient choice - Cesarean: The role of evidence and ethics F.A. Chervenak, USA
	Elective preterm delivery for all monochorionic (MC) twins? I. Blickstein, Israel
	Management of complicated MC twins J. Deprest, Belgium
	Outcome of multiple pregnancies - 2010: Spontaneous vs. iatrogenic M. Carrapato, Portugal
Objectives	To respect the impact of iatrogenic prematurity caused by Cesarean delivery
	* To provide ethical appropriate strategies for dealing with patient-requested Cesarean delivery * To understand hot controversies in the management of multiple pregnancies